178 related articles for article (PubMed ID: 35441217)
1. Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases.
Yngvadottir B; Andreou A; Bassaganyas L; Larionov A; Cornish AJ; Chubb D; Saunders CN; Smith PS; Zhang H; Cole Y; Research Consortium GE; Larkin J; Browning L; Turajlic S; Litchfield K; Houlston RS; Maher ER
Hum Mol Genet; 2022 Aug; 31(17):3001-3011. PubMed ID: 35441217
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
Nguyen CB; Knaus C; Li J; Accardo ML; Koeppe E; Vaishampayan UN; Alva AS; Else T
JCO Precis Oncol; 2023 Sep; 7():e2300168. PubMed ID: 38127826
[TBL] [Abstract][Full Text] [Related]
3. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic germline variants in patients with features of hereditary renal cell carcinoma: Evidence for further locus heterogeneity.
Smith PS; West H; Whitworth J; Castle B; Sansbury FH; Warren AY; Woodward ER; Tischkowitz M; Maher ER
Genes Chromosomes Cancer; 2021 Jan; 60(1):5-16. PubMed ID: 32830346
[TBL] [Abstract][Full Text] [Related]
5. Trans-ethnic variation in germline variants of patients with renal cell carcinoma.
Abou Alaiwi S; Nassar AH; Adib E; Groha SM; Akl EW; McGregor BA; Esplin ED; Yang S; Hatchell K; Fusaro V; Nielsen S; Kwiatkowski DJ; Sonpavde GP; Pomerantz M; Garber JE; Freedman ML; Rana HQ; Gusev A; Choueiri TK
Cell Rep; 2021 Mar; 34(13):108926. PubMed ID: 33789101
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma.
Santos M; Lanillos J; Roldan-Romero JM; Caleiras E; Montero-Conde C; Cascón A; Climent MA; Anguera G; Hernando S; Laínez N; Robledo M; Robles L; de Velasco G; García-Donas J; Rodriguez-Antona C
Genet Med; 2021 Apr; 23(4):698-704. PubMed ID: 33442023
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
Carlo MI; Mukherjee S; Mandelker D; Vijai J; Kemel Y; Zhang L; Knezevic A; Patil S; Ceyhan-Birsoy O; Huang KC; Redzematovic A; Coskey DT; Stewart C; Pradhan N; Arnold AG; Hakimi AA; Chen YB; Coleman JA; Hyman DM; Ladanyi M; Cadoo KA; Walsh MF; Stadler ZK; Lee CH; Feldman DR; Voss MH; Robson M; Motzer RJ; Offit K
JAMA Oncol; 2018 Sep; 4(9):1228-1235. PubMed ID: 29978187
[TBL] [Abstract][Full Text] [Related]
8. Integrative Analysis of Germline Rare Variants in Clear and Non-Clear Cell Renal Cell Carcinoma.
Han S; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
medRxiv; 2023 Jan; ():. PubMed ID: 36712083
[TBL] [Abstract][Full Text] [Related]
9. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.
Han SH; Camp SY; Chu H; Collins R; Gillani R; Park J; Bakouny Z; Ricker CA; Reardon B; Moore N; Kofman E; Labaki C; Braun D; Choueiri TK; AlDubayan SH; Van Allen EM
Eur Urol Open Sci; 2024 Apr; 62():107-122. PubMed ID: 38496821
[TBL] [Abstract][Full Text] [Related]
11. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic germline variants in BRCA1 and TP53 increase lung cancer risk in Chinese.
Wei B; Zhao J; Li J; Feng J; Sun M; Wang Z; Shi C; Yang K; Qin Y; Zhang J; Ma J; Dong H
Cancer Med; 2023 Dec; 12(23):21219-21228. PubMed ID: 37930190
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.
Kim J; Light N; Subasri V; Young EL; Wegman-Ostrosky T; Barkauskas DA; Hall D; Lupo PJ; Patidar R; Maese LD; Jones K; Wang M; Tavtigian SV; Wu D; Shlien A; Telfer F; Goldenberg A; Skapek SX; Wei JS; Wen X; Catchpoole D; Hawkins DS; Schiffman JD; Khan J; Malkin D; Stewart DR
JCO Precis Oncol; 2021; 5():. PubMed ID: 34095712
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
[TBL] [Abstract][Full Text] [Related]
15. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
16. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
AlDubayan SH; Pyle LC; Gamulin M; Kulis T; Moore ND; Taylor-Weiner A; Hamid AA; Reardon B; Wubbenhorst B; Godse R; Vaughn DJ; Jacobs LA; Meien S; Grgic M; Kastelan Z; Markt SC; Damrauer SM; Rader DJ; Kember RL; Loud JT; Kanetsky PA; Greene MH; Sweeney CJ; Kubisch C; Nathanson KL; Van Allen EM; Stewart DR; Lessel D;
JAMA Oncol; 2019 Apr; 5(4):514-522. PubMed ID: 30676620
[TBL] [Abstract][Full Text] [Related]
17. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
18. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
[TBL] [Abstract][Full Text] [Related]
19. The germline mutational landscape of genitourinary cancers and its indication for prognosis and risk.
Yang Y; Zhang G; Hu C; Luo W; Jiang H; Liu S; Yang H
BMC Urol; 2022 Nov; 22(1):196. PubMed ID: 36451132
[TBL] [Abstract][Full Text] [Related]
20. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]